Clinical data | |
---|---|
Trade names | Selexid, Melysin, Coactabs, others |
Other names | amdinocillin pivoxil (USAN US) |
AHFS/Drugs.com | Monograph |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Low |
Protein binding | 5 to 10% (as mecillinam) |
Metabolism | Pivmecillinam is hydrolyzed to mecillinam |
Elimination half-life | 1 to 3 hours |
Excretion | Kidney and biliary, mostly as mecillinam |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.046.600 |
Chemical and physical data | |
Formula | C21H33N3O5S |
Molar mass | 439.57 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pivmecillinam (INN), or amdinocillin pivoxil (USAN), sold under the brand name Selexid and Pivya among others, is an orally active prodrug of mecillinam, an extended-spectrum penicillin antibiotic. Pivmecillinam is the pivaloyloxymethyl ester of mecillinam.
The most common side effects include nausea and diarrhea.[2]